Navigation Links
Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
Date:11/16/2007

KENILWORTH, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that it has received antitrust clearance from the U.S. Federal Trade Commission (FTC) regarding its planned acquisition of Organon BioSciences N.V. from Akzo Nobel N.V., as announced March 12, 2007.

Organon BioSciences is comprised mainly of Organon, the human pharmaceutical business, and Intervet, the animal health business. It also includes Nobilon, the human vaccine development unit, and Diosynth, the third- party manufacturing unit of Organon.

In connection with the conditional clearance, Schering-Plough and Intervet will divest three poultry vaccines in the United States. The divestitures are not material to the company's financial results. No divestitures of human health products are required.

Schering-Plough received approval from The European Commission on Oct. 11, 2007, and continues to expect the transaction to be completed by year-end 2007.

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its approximately 33,500 people around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.

DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Sec
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
2. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
3. Schering-Plough Reports Financial Results for Third Quarter of 2007
4. Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
5. Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
6. Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference
7. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
8. DaVita Receives Civil Complaint
9. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
10. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
11. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...thertoShareRecordsSafely,ImproveCare ,, WASHI...ofVeteransAffairs(VA)andKaiserPermanentetodayannou...cestoourNation,sheroes.VAandKaiserPermanentearelau...d(EHR)informationusingtheNationwideHealthInformati...manServices. ,, "Theabilitytosharecriticalhealt...
(Date:11/25/2009)...Nov.25/PRNewswire/--dazzlesmile,llc www.dazzlesmil...hscience.com havefileda67-pagefederallawsuitagains...esseWillms,FarendServicesLimited,andAtLastFulfillm...istrictCourtfortheDistrictofUtah,allegesmassivenat...brandedteethwhiteningproducts,violationsoftheRacke...
(Date:11/25/2009)...,Nov.25/PRNewswire/--DanielTouizer,CEOof Ci n e...uehealthinsurancebenefitprograms,isconcernedthatth...arlyoneinfiveAmericansarewithoutafull-timejobandun...ntratesaredeterminedbytheU-6number,whichhasspikedt... l T ouizer ."Thesestatisticsarealarmingasitmea...
(Date:11/25/2009)...naling pathways essential to normal human developm...factor receptor (EGFR) pathways - interact in ways...is, researchers from The University of Texas M. D....e of Molecular Cell . , This newly characterize...known to correlate with invasive cancer - activati...
(Date:11/25/2009)...American Society of,Hematology (ASH) is pleased t...,the highest scoring abstracts in the categories ...te student, resident physician, and post-doctoral,...rium plus annual meeting,travel reimbursement. ,...raduate,Student , Kimberly Fan , Donor Dendri...
Breaking Medicine News(10 mins):Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:ASH announces 2009 Merit Award winners 2
...a., Feb. 18 The Quantum Group,Inc. (NYSE Amex: ...el J. Guillama,commented on the President signing ... into law yesterday. The new law allocates $19.2 ..., The new law provides for approximately $17 b...
...., Feb. 18 In a dramatic move to unite the,power ...organizations, the,United American Nurses, Califor...Committee, and the Massachusetts Nurses Associatio...urses-National,Nurses Organizing Committee, UAN-NN...
... Express flights not always owned and operat...f care , Cleveland, Ohio ...lane crash of Continental Flight 3407 near Buffa...expert and lawyer Jamie R. Lebovitz points out tha...
... JIVA™ Resveratrol Synergistic Supplem... Mount Kisco, NY (PRWEB) Febr...ated as much excitement as resveratrol . It,s bee...ute on Aging created a stir when they published a ...
... Conference Call for Wednesday, February 18, 2009 ...difast, Inc. (NYSE: MED ), a leading clinically-...unced today that it will hold an investor call at ...y Minkow and the Fraud Discovery Institute. , , "...
...livers Critical Support to Hispanic Family Budgets...dent and CEO of the National Alliance for Hispanic...cacy group, delivered the following statement on t...panic families are an illness or hospital stay awa...
Other Medicine News:Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 2Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 3Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 4Health News:Aviation Expert Addresses Flight Safety Concerns 2Health News:Aviation Expert Addresses Flight Safety Concerns 3Health News:Aviation Expert Addresses Flight Safety Concerns 4Health News:Physician Develops Resveratrol Evidence-Based Nutraceutical for Heart Health 2Health News:Physician Develops Resveratrol Evidence-Based Nutraceutical for Heart Health 3Health News:Medifast, Inc. Responds to False Claims 2Health News:Medifast, Inc. Responds to False Claims 3Health News:Medifast, Inc. Responds to False Claims 4Health News:Statement of the National Alliance for Hispanic Health on Signing of the American Recovery and Reinvestment Act 2
(Date:11/25/2009).../PRNewswire/--AccordingtoMillenniumResearchGroup(M...elligence,thenearly$3billionUSmarketfortraumafixat...iveyearsdespitetherecenteconomicslowdown.MRG,s USM...rketwillremainhighlydynamicoverthenextfiveyears,wi...uslyunderservedsegmentsofthetraumafixationmarket,f...
(Date:11/25/2009)...swire/--Reportlinker.comannouncesthatanewmarketres...nasalDrugDelivery-USMarketTrends&Analysis htt...Delivery---US-Market-Trends--Analysis.html ,, ...ansionoftherapeuticapplicationsfromthedeliveryofco...emictherapeuticdrugs.Thefutureofthetechnologyhinge...
(Date:11/24/2009)...PRNewswire-Asia/--ChindexInternational,Inc.,("Chin...oviderofWestern,healthcareproductsandservicesinthe...anywillattendthe21stAnnualPiperJaffray,"Unplugged"...e,NewYorkPalaceHotel. , Managementiscurrently...2009,andholdone-on-onemeetingsthroughouttheday.Awe...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Innovative Psoriasis Treatment PSORENT 28R 29 Announces Healthcare Cost Savings Potential Consistent with President Obamas Announcement on Healthcare 4651 1Innovative Psoriasis Treatment PSORENT 28R 29 Announces Healthcare Cost Savings Potential Consistent with President Obamas Announcement on Healthcare 4651 2YWCAs to Mark National HIV Testing Day on June 27 50064 1YWCAs to Mark National HIV Testing Day on June 27 50064 2Bills Address Long Waits for Behavioral Health Patients 50063 1Bills Address Long Waits for Behavioral Health Patients 50063 2Bills Address Long Waits for Behavioral Health Patients 50063 3
...hilcott Limited (Nasdaq: WCRX ) announced today ...rnational Pty. Ltd. ("Mayne"), a subsidiary of Hos...tual Pharmaceutical Company, Inc. ("Mutual"), Myla...ories, Inc. ("Impax") in the District Court for t...e,s U.S. Patent No. 6,958,161 (the ",161 Patent") ...
...me that normal stem cells can act as the source of...Tenn., Dec. 17 /PRNewswire-USNewswire/ -- Scient... answered a central question in cancer biology: wh...tem cells are immature cells that can renew themse...that compose the range of body tissues. In recent ...
Other Medicine Technology:Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 3
SEDIPLAST ESR SYSTEM (with diluent)
SEDIPLAST ESR SYSTEM (without diluent)
Hemaprompt FG Gastric and Fecal Occult Blood Test
... occult blood test (FOBT) has been aiding physicia... an early indication of colorectal cancer. More th...hich were conducted over long periods of time with...d in leading medical journals around the world. As...
Medicine Products: